Fernandez-Fernandez et al
Alt: Hair loss timeline during semaglutide and tirzepatide treatment showing recovery phases Lean muscle mass loss: a critical comparison This is arguably the most important side effect comparison that most guides barely mention
GSH/GSSG is a reliable indicator of cellular redox status, and a chronic reduction in GSH/GSSG reflects a reduced antioxidant capacity and increased vulnerability to oxidative damage
Phase 2 trial data show gastrointestinal adverse events including nausea, vomiting, and upper abdominal discomfort are among the most common side effects, particularly at higher doses
This knowledge will be crucial in optimising the benefit-risk profile and guiding informed decision-making regarding the use of retatrutide in the management of obesity and related conditions
GLP-1 helps you feel fuller for longer, reduces cravings, and supports healthier eating habits